Eli Lilly's Retatrutide Demonstrates Record Weight Loss and Reverses Obesity Complications

Indianapolis, Sunday, 7 June 2026.
June 2026 data reveals Eli Lilly’s retatrutide drives a groundbreaking 38.6 kg average weight loss over 104 weeks, simultaneously reversing severe sleep apnea and osteoarthritis pain.